mhurhangee/patent-ind-claim-en huggingface dataset:
An artificial heart valve stent, comprising: a tubular stent body having an inflow side end and an outflow side end opposite to the inflow side, an inflow side skirt surrounding the external wall of the stent body , and an outflow side skirt surrounding the external wall of the stent body , wherein in a released state, free ends of both the inflow side skirt and the outflow side skirt extend towards the inflow side end and wherein the inflow side skirt is configured for cooperating with the outflow side skirt to clamp heart valve tissues, characterized in that the artificial heart valve stent further comprises a tubular connection stent surrounding the external wall of the stent body , and the inflow side skirt and the outflow side skirt are located at either end of the tubular connection stent , respectively, and the tubular connection stent and the stent body are formed independently and then are fixedly connected into a whole. a tubular stent body having an inflow side end and an outflow side end opposite to the inflow side, an inflow side skirt surrounding the external wall of the stent body , and an outflow side skirt surrounding the external wall of the stent body , wherein in a released state, free ends of both the inflow side skirt and the outflow side skirt extend towards the inflow side end and wherein the inflow side skirt is configured for cooperating with the outflow side skirt to clamp heart valve tissues, characterized in that the artificial heart valve stent further comprises a tubular connection stent surrounding the external wall of the stent body , and the inflow side skirt and the outflow side skirt are located at either end of the tubular connection stent , respectively, and the tubular connection stent and the stent body are formed independently and then are fixedly connected into a whole.
Low-pressure plasma chamber for a low-pressure plasma installation for plasma processing of a component in the low-pressure plasma chamber , wherein the low-pressure plasma chamber has a low-pressure plasma chamber body of glass or porcelain, wherein the low-pressure plasma chamber body has an at least partially closed rear wall of glass or porcelain, wherein the low-pressure plasma chamber body has an opening having a collar , wherein the low-pressure plasma chamber body is formed in one piece, wherein the cross-section of the low-pressure plasma chamber body is constructed to be rectangular, characterized in that the low-pressure plasma chamber has a door which can be opened and closed in a reversible manner without tools, wherein the door is secured to the collar.
An accelerometer system comprising: a first electromagnetic coil ; a first excitation ring comprising: a first housing ; and a first cover removably attached to the first housing, wherein the first housing and the first cover define a first recess configured to house the first electromagnetic coil; a second electromagnetic coil ; a second excitation ring comprising: a second housing ; and a second cover removably attached to the second housing, wherein the second housing and the second cover define a second recess configured to house the second electromagnetic coil; and a proof mass assembly positioned between the first excitation ring and the second excitation ring, wherein the first electromagnetic coil is configured to generate a first magnetic flux that flows through the first excitation ring and maintains a proof mass of the proof mass assembly in a null position, and wherein the second electromagnetic coil is configured to generate a second magnetic flux that flows through the second excitation ring and maintains the proof mass in the null position. a first electromagnetic coil ; a first excitation ring comprising: a first housing ; and a first cover removably attached to the first housing, wherein the first housing and the first cover define a first recess configured to house the first electromagnetic coil; a first housing ; and a first cover removably attached to the first housing, wherein the first housing and the first cover define a first recess configured to house the first electromagnetic coil; a second electromagnetic coil ; a second excitation ring comprising: a second housing ; and a second cover removably attached to the second housing, wherein the second housing and the second cover define a second recess configured to house the second electromagnetic coil; and a second housing ; and a second cover removably attached to the second housing, wherein the second housing and the second cover define a second recess configured to house the second electromagnetic coil; and a proof mass assembly positioned between the first excitation ring and the second excitation ring, wherein the first electromagnetic coil is configured to generate a first magnetic flux that flows through the first excitation ring and maintains a proof mass of the proof mass assembly in a null position, and wherein the second electromagnetic coil is configured to generate a second magnetic flux that flows through the second excitation ring and maintains the proof mass in the null position.
A method for identifying PD1+ immune cells in a sample, comprising analyzing the methylation status of at least one CpG position in the mammalian gene region for Programmed cell death 1 (PDCD1), wherein said at least one CpG position is selected from a CpG selected from the CpG positions 27, 47, 82, 136, 194, 197, 249, 285, 290, 303, 336, 354, and 369 in the amplicon 1876 according to SEQ ID No. 2, CpG positions 31, 60, 75, 86, 114, 138, 142, 171, 184, 210, 217, and 241 in the amplicon 1877 according to SEQ ID No. 3, CpG positions 35, 56, 74, 104, 118, 130, 150, 182, 196, and 212 in the amplicon 1878 according to SEQ ID No. 4, and is preferably selected from CpG positions 60, 75, 86, 114, 138, 142, 171, 184, 210, 217, and 241 in a fragment of the amplicon 1877 according to SEQ ID No. 3, and wherein a demethylation or lack of methylation of the CpG positions in said gene region to at least 70% is indicative for a PD1+ immune cell, when compared to a non-PD1+ cell.
A load control device for controlling an amount of power delivered from an alternating current, AC, power source to an electrical load , the load control device comprising: a bidirectional semiconductor switch configured to be coupled between the AC power source and the electrical load; and a controller operatively coupled to the bidirectional semiconductor switch, wherein the controller is configured to determine to operate the electrical load in a subsequent operation via a phase control signal in a forward phase-control mode; characterised in that the controller is further configured to: after determining to operate the electrical load in a subsequent operation via a phase control signal in a forward phase-control mode, when transitioning from an electronic off state to an electronic on state, control the bidirectional semiconductor switch to provide the phase control signal in a reverse phase-control mode for a predetermined period of time (T RPC ) to the electrical load: before using the forward phase-control mode; after said predetermined period of time (T RPC ) switch the phase control signal to the forward phase-control mode and control the bidirectional switch to provide the phase control signal in the forward phase-control mode to the electrical load. a bidirectional semiconductor switch configured to be coupled between the AC power source and the electrical load; and a controller operatively coupled to the bidirectional semiconductor switch, wherein the controller is configured to determine to operate the electrical load in a subsequent operation via a phase control signal in a forward phase-control mode; after determining to operate the electrical load in a subsequent operation via a phase control signal in a forward phase-control mode, when transitioning from an electronic off state to an electronic on state, control the bidirectional semiconductor switch to provide the phase control signal in a reverse phase-control mode for a predetermined period of time (T RPC ) to the electrical load: before using the forward phase-control mode; after said predetermined period of time (T RPC ) switch the phase control signal to the forward phase-control mode and control the bidirectional switch to provide the phase control signal in the forward phase-control mode to the electrical load.
Assembly, comprising a slot nut for mounting in a mounting rail , having at least one form-fitting portion , and the mounting rail , which has a rail portion which can engage in the form-fitting portion of the slot nut with the formation of a form fit, wherein the slot nut and a slotted receiving portion of the mounting rail are dimensioned and shaped in such a way that the slot nut can be inserted perpendicularly to the rail longitudinal direction through a slot , which extends in the rail longitudinal direction, into the slotted receiving portion of the mounting rail and can be brought into its final mounting position therein as a result of rotation or pivoting.
Electrical installation comprising a permanent-magnet synchronous motor , a three-phase inverter and a control device , the inverter being adapted for generating a three-phase electrical current (C) and for supplying the permanent-magnet synchronous motor with this current (C), the current presenting a first frequency (f1) for operating the permanent-magnet synchronous motor , the current (C) also comprising an undesired frequency component presenting a second frequency (f2), and the control device comprising : - a measurement module adapted for measuring a parameter (p1, p2, p3) of each phase (P1, P2, P3) of the current (C), the measured parameters (p1, p2, p3) forming a measurement vector (Vm), - a first Clarke calculation module adapted for calculating a Clarke transform of the measurement vector (Vm), the Clarke transform comprising a first vector (V1) containing two first values (v1), the first vector (V1) being represented in a first basis of a two-dimensional vector space, and - a command module for generating a control signal for controlling the inverter , the installation being characterized by the control device further comprising: - a first rotation module adapted for generating a second vector (V2) containing two second values (v2), the second vector (V2) being a representation of the first vector (V1) in a second basis of the vector space, the second basis rotating at the second frequency (f2) with respect to the first basis, and - a first subtraction module adapted for comparing each second value (v2) to a corresponding first reference value (r1) for generating a corresponding first difference (d1), and by the command module being adapted for generating the control signal from at least the first differences (d1). - a measurement module adapted for measuring a parameter (p1, p2, p3) of each phase (P1, P2, P3) of the current (C), the measured parameters (p1, p2, p3) forming a measurement vector (Vm), - a first Clarke calculation module adapted for calculating a Clarke transform of the measurement vector (Vm), the Clarke transform comprising a first vector (V1) containing two first values (v1), the first vector (V1) being represented in a first basis of a two-dimensional vector space, and - a command module for generating a control signal for controlling the inverter , - a first rotation module adapted for generating a second vector (V2) containing two second values (v2), the second vector (V2) being a representation of the first vector (V1) in a second basis of the vector space, the second basis rotating at the second frequency (f2) with respect to the first basis, and - a first subtraction module adapted for comparing each second value (v2) to a corresponding first reference value (r1) for generating a corresponding first difference (d1),
A urethane (meth)acrylate comprising residual isocyanate groups, which is obtained from the reaction of: a) at least one di- or poly-isocyanate, and b) at least one hydroxyl-functional (meth)acrylic acid ester of at least one polymer chain which comprises: at least one (meth)acryloyl group, at least one free hydroxyl group and at least one polymer chain, wherein the equivalent ratio of OH groups to NCO groups is 0.05:1 to 0.66:1. a) at least one di- or poly-isocyanate, and b) at least one hydroxyl-functional (meth)acrylic acid ester of at least one polymer chain which comprises: at least one (meth)acryloyl group, at least one free hydroxyl group and at least one polymer chain,
An ophthalmic composition comprising: i) a nitric oxide releasing phosphodiesterase type 5 inhibitor selected from: - [ -1-(4-{[(3-chloro-4-methoxyphenyl)methyl]amino}-5-{[(pyrimidin-2-yl)methyl] carbamoyl}pyrimidin-2-yl)pyrrolidin-2-yl]methyl 6-(nitrooxy)hexanoate or a pharmaceutically acceptable salt thereof, ii) a prostaglandin analog selected from: latanoprost, bimatoprost, travoprost or tafluprost. i) a nitric oxide releasing phosphodiesterase type 5 inhibitor selected from: - [ -1-(4-{[(3-chloro-4-methoxyphenyl)methyl]amino}-5-{[(pyrimidin-2-yl)methyl] carbamoyl}pyrimidin-2-yl)pyrrolidin-2-yl]methyl 6-(nitrooxy)hexanoate or a pharmaceutically acceptable salt thereof, - [ -1-(4-{[(3-chloro-4-methoxyphenyl)methyl]amino}-5-{[(pyrimidin-2-yl)methyl] carbamoyl}pyrimidin-2-yl)pyrrolidin-2-yl]methyl 6-(nitrooxy)hexanoate or a pharmaceutically acceptable salt thereof, ii) a prostaglandin analog selected from: latanoprost, bimatoprost, travoprost or tafluprost.
Turbomachine comprising an annular flow channel and a housing structure surrounding the flow channel, and a plurality of guide vanes and rotor blades which are arranged in the flow channel, the rotor blades being rotatably received in the housing structure, while the guide vanes are stationary in the housing structure, and a plurality of guide vanes forming an annular guide vane ring, and the housing structure, in the region of the radially inner flow channel boundary, having a seal for sealing against hot gas exiting the flow channel, which seal is arranged on guide vane roots of the guide vanes of the guide vane ring via a seal carrier and seals against a rotatable sealing surface, the seal carrier , at a radially outer end, having a connection region for arrangement on the guide vane roots and, at a radially inner end, having an arrangement region for arranging the seal , characterized in that the seal carrier is formed from an intermetallic material.
A system for a method of treating hypoglycemia, wherein the system comprises means to: - detect a hypoglycemic condition using a continuous blood glucose monitor of the system that monitors blood glucose levels of a patient on a continuous basis over a period of time; - determine whether the hypoglycemic condition is either a minor hypoglycemic condition, corresponding to the blood glucose level of the patient being below a first configurable blood glucose level, or a major hypoglycemic condition, corresponding to the blood glucose level of the patient being below a second configurable blood glucose level, the second configurable blood glucose level being lower than the first configurable blood glucose level; - provide a first alarm alerting of the hypoglycemic condition if the hypoglycemic condition is a minor hypoglycemic condition; - provide a second alarm alerting of the hypoglycemic condition if the hypoglycemic condition is a major hypoglycemic condition; and - deliver insulin and glucagon to the patient using a dual pump implementation of an alarm and injector apparatus of the system comprising - an insulin reservoir , - a glucagon reservoir , - an insulin delivery mechanism for use in delivering insulin from the insulin reservoir to the patient, and - a glucagon delivery mechanism for delivering glucagon from the glucagon reservoir to the patient, and configured to automatically deliver glucagon if after a predetermined time period the second alarm is not acknowledged. - detect a hypoglycemic condition using a continuous blood glucose monitor of the system that monitors blood glucose levels of a patient on a continuous basis over a period of time; - determine whether the hypoglycemic condition is either a minor hypoglycemic condition, corresponding to the blood glucose level of the patient being below a first configurable blood glucose level, or a major hypoglycemic condition, corresponding to the blood glucose level of the patient being below a second configurable blood glucose level, the second configurable blood glucose level being lower than the first configurable blood glucose level; - provide a first alarm alerting of the hypoglycemic condition if the hypoglycemic condition is a minor hypoglycemic condition; - provide a second alarm alerting of the hypoglycemic condition if the hypoglycemic condition is a major hypoglycemic condition; and - deliver insulin and glucagon to the patient using a dual pump implementation of an alarm and injector apparatus of the system comprising - an insulin reservoir , - a glucagon reservoir , - an insulin delivery mechanism for use in delivering insulin from the insulin reservoir to the patient, and - a glucagon delivery mechanism for delivering glucagon from the glucagon reservoir to the patient, - an insulin reservoir , - a glucagon reservoir , - an insulin delivery mechanism for use in delivering insulin from the insulin reservoir to the patient, and - a glucagon delivery mechanism for delivering glucagon from the glucagon reservoir to the patient,
Release-matrix for controlled release of a nutrient, inducer or pH controlling agent into a medium, comprising a cross-linked polymer system based on a polysiloxane, a reactive polysiloxane and a nutrient, inducer or pH controlling agent embedded therein, characterized in that the particle size of the nutrient, inducer or pH controlling agent is from 1-20 μm, and wherein the nutrient, inducer or pH controlling agent is distributed homogeneously in the release-matrix.
A method for wireless communication at a user equipment, UE, comprising: receiving a configuration of a first one or more channel state information, CSI, reference signal, CSI-RS, resources for channel measurement and a configuration of a second one or more CSI-RS resources for interference measurement ; characterised by : receiving an indicator indicating a categorization of each port used to transmit on the second one or more CSI-RS resources for interference measurement as corresponding to one of a first type of layer or a second type of layer wherein the first type of layer or the second type of layer is a non-linear precoding layer; and transmitting a CSI report based at least in part on the configuration of the first one or more CSI-RS resources, the configuration of the second one or more CSI-RS resources, and the categorization . receiving a configuration of a first one or more channel state information, CSI, reference signal, CSI-RS, resources for channel measurement and a configuration of a second one or more CSI-RS resources for interference measurement ; characterised by : receiving an indicator indicating a categorization of each port used to transmit on the second one or more CSI-RS resources for interference measurement as corresponding to one of a first type of layer or a second type of layer wherein the first type of layer or the second type of layer is a non-linear precoding layer; and transmitting a CSI report based at least in part on the configuration of the first one or more CSI-RS resources, the configuration of the second one or more CSI-RS resources, and the categorization . receiving an indicator indicating a categorization of each port used to transmit on the second one or more CSI-RS resources for interference measurement as corresponding to one of a first type of layer or a second type of layer wherein the first type of layer or the second type of layer is a non-linear precoding layer; and transmitting a CSI report based at least in part on the configuration of the first one or more CSI-RS resources, the configuration of the second one or more CSI-RS resources, and the categorization .
Waveguide for treating inner walls of inner pathways of a human body with energy waves, wherein the waveguide comprises a first longitudinal end for receiving energy waves, a second longitudinal end for redirecting the energy waves that travelled from the first longitudinal end through the waveguide to the second longitudinal end , the first and second longitudinal ends being opposite ends of the waveguide along a longitudinal extend (L) of the waveguide , and a lateral side that extends from the first longitudinal end to the second longitudinal end along the longitudinal extend (L), wherein the second longitudinal end comprises at least one redirection surface provided by the waveguide , the redirection surface being unpolished, characterized in that the redirection surface comprises a predefined roughness with a roughness parameter R a between 0,5 μm and 10 μm. a first longitudinal end for receiving energy waves, a second longitudinal end for redirecting the energy waves that travelled from the first longitudinal end through the waveguide to the second longitudinal end , the first and second longitudinal ends being opposite ends of the waveguide along a longitudinal extend (L) of the waveguide , and a lateral side that extends from the first longitudinal end to the second longitudinal end along the longitudinal extend (L), wherein the second longitudinal end comprises at least one redirection surface provided by the waveguide , the redirection surface being unpolished, characterized in that the redirection surface comprises a predefined roughness with a roughness parameter R a between 0,5 μm and 10 μm.
An orthopaedic implant comprising: an elongate body having an outer wall; one or more openings through the outer wall; and a cannulation disposed in a longitudinal direction along a length of the body and defined by the outer wall, wherein the cannulation has a substantially uniform diameter in the longitudinal direction, characterized in that the body is configured such that stresses are evenly distributed along the length of the body by providing discrete sections along the length of the body, each having a different material density that is optimized for evenly distributing stress. an elongate body having an outer wall; one or more openings through the outer wall; and a cannulation disposed in a longitudinal direction along a length of the body and defined by the outer wall, wherein the cannulation has a substantially uniform diameter in the longitudinal direction, characterized in that the body is configured such that stresses are evenly distributed along the length of the body by providing discrete sections along the length of the body, each having a different material density that is optimized for evenly distributing stress.